Clinical Trial Update: Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for botulinic toxin injections in plantar lesions of Epidermolysis Bullosa Simplex across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidermolysis Bullosa Simplex

Drugs mentioned

• botulinic toxin (botulinic toxin)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Epidermolysis Bullosa Simplex | Phase 2, Phase 3 | Status: UNKNOWN